Clinical Trials Directory

Trials / Completed

CompletedNCT00750932

Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis

Study of the Biodistribution of PMN Serine Proteases in Sputum of Patients Affected by Cystic Fibrosis: Towards New Anti-inflammatory Therapies

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Accepted

Summary

The purpose of the proposed project is to characterize the neutrophile proteases which participate in the chronic inflammatory phenomenon associated with the cystic fibrosis and which are responsible for the degradation of the lung tissue. The respiratory failure which results from it is one of main causes of the fatal evolution of this pathology but the anti-inflammatory therapies based on the use of antiproteases targeting specifically the soluble elastase did not end, until now, in the hoped results. The identification of the other noxious targets is a crucial element to give new orientations to the anti-inflammatory strategies based on the administration of antiproteases which remain a promising way.

Conditions

Timeline

Start date
2008-01-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2008-09-11
Last updated
2017-02-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00750932. Inclusion in this directory is not an endorsement.

Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis (NCT00750932) · Clinical Trials Directory